TRAIL protects against endothelium injury in diabetes via Akt-eNOS signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRAIL protects against endothelium injury in diabetes via Akt-eNOS signaling

Published:2014-12 Issue:2 Volume:237 Page:718-724
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Liu Min,Xiang Guangda,Lu Junyan,Xiang Lin,Dong Jing,Mei Wen

Funder

National Foundation of Natural Science

Natural Science Foundation of Hubei Province

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules;Park;Curr. Opin. Cell. Biol.,2005

2. An antagonist decoy receptor and a death domain-containing receptor for TRAIL;Pan;Science,1997

3. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways;Secchiero;Circulation,2003

4. Expression, regulation and function of trail in atherosclerosis;Kavurma;Biochem. Pharmacol.,2008

5. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice;Secchiero;Circulation,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of Macrovascular Complications in Diabetes;Textbook of Diabetes;2024-01-12

2. Expression of insulin-like growth factor binding protein-3 in HELLP syndrome;BMC Pregnancy and Childbirth;2023-11-10

3. Expression of Insulin-Like Growth Factor Binding Protein-3 in HELLP Syndrome;2023-06-19

4. Exogenous Hydrogen Sulfide Activates PI3K/Akt/eNOS Pathway to Improve Replicative Senescence in Human Umbilical Vein Endothelial Cells;Cardiology Research and Practice;2023-04-06

5. The Prognostic, Diagnostic, and Therapeutic Potential of TRAIL Signalling in Cardiovascular Diseases;International Journal of Molecular Sciences;2023-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3